"Dayima" Parent Company KangSeed Technology Ltd. Files IPO Prospectus
Events & Perspectives
Let’s start with the viral sensation that dominated WeChat Moments last week: NASA discovered a new planet, and people around the world went wild. Environmentalists urged, “Don’t ruin this new world.” Mystics speculated, “Immortals might be living there.” Scientists remarked, “We can finally search for extraterrestrial life—isn’t so-and-so coming back soon?” Singles sighed deeply, “Even Earth has found a partner; I’m so ‘thrilled’ (read: devastated).” Those in long-distance relationships commented, “Now this is what you call a long-distance relationship—separated by countless light-years.”
So... will housing prices on Earth drop?
So.. I don't know how.
So... let’s take a look at the major events that unfolded around us last week.
Baidu Waimai Integrates with Online Pharmacy Platform, Promising Medication Delivery to Your Doorstep in as Little as One Hour.
According to VCBeat, Baidu Waimai began rolling out its pharmaceutical section in early July, claiming delivery times as fast as one hour. Baidu Waimai disclosed that well-known online and offline pharmacy platforms, including Yaogeli, 111.com.cn, Jingwei Pharmacy, and Baixing Yangguang Pharmacy, will be gradually integrated into the Baidu Waimai platform, with Beijing serving as the core hub for nationwide expansion. The delivery model combines self-delivery by the platform and pharmacies with services provided by “Baidu Waimai riders.” Once users place orders through the pharmacy platforms integrated into Baidu Waimai, deliveries can be completed in as little as one hour.
Baidu Waimai has launched nearly 1,000 pharmaceutical products across more than ten categories, including household essentials, cold and cough remedies, heat-clearing and detoxifying agents, and antipyretic analgesics, thereby covering the majority of over-the-counter (OTC) medications required for daily use.
From this event, it can be observed that since B has arrived, AT should not be far behind.
Guahao.com Announces Construction of First Cloud Hospital.
Recent media reports indicate that Guahaowang plans to build its first cloud hospital, which will be located in Wuzhen Town, Tongxiang County, Jiaxing City, Zhejiang Province, and is scheduled to commence operations before the second World Internet Conference. According to insiders at Guahaowang, the company will invest tens of millions of yuan in the first phase of the internet hospital’s construction. Clearly, this internet hospital holds a significant position in Guahaowang’s strategic layout.
“Dayima” Finds “Dayifu.”
On the evening of July 20, By-Health disclosed that its wholly-owned subsidiary, Hong Kong Bairui Co., Ltd., had invested $10 million of its own funds in KangSeed Technology Ltd., the holding company of the female-focused app “Dayima.” On the same day, “Meiri Meijia,” By-Health’s independent internet health food brand, also entered into a strategic cooperation agreement with Dayima.
Observing By-Health’s external investment activities over the past year—including taking a stake in Beitai, acquiring Shanghai Zhending, establishing the internet healthcare subsidiary Taogu Technology, investing in the cross-border e-commerce platform Youkeshu, and forming a strategic partnership with Ping An Good Doctor—it is evident that the company is aggressively executing its self-developed “combination strategy.”
Jiuzhoutong and Yiling Pharmaceutical Establish Strategic Partnership
Last week, Jointown Pharmaceutical Group Co., Ltd. announced that it had signed a "Group Strategic Cooperation Agreement" with Shijiazhuang Yiling Pharmaceutical Co., Ltd. The main contents of the cooperation are as follows:
1. Jointown leverages its established nationwide pharmaceutical distribution platform to assist Yiling Pharmaceutical in comprehensively enhancing the sales capabilities of its directly manufactured pharmaceutical products and intensifying market development efforts;
2. Both parties shall leverage their respective resource advantages, corporate strengths, and market influence to establish complementary and mutually supportive cooperation in areas such as e-commerce, procurement, supply, and marketing of traditional Chinese medicinal materials and raw materials;
3. The total volume of various businesses under the strategic cooperation between both parties shall strive to reach an annual target of RMB 1.5 billion within three years, and an annual target of RMB 2 billion within five years, from the effective date of this Agreement;
4. Both parties recognize each other as strategic partners and commit to engaging in in-depth exchanges in future project collaboration, product market exploration, corporate promotion, and employee training, thereby jointly contributing to the development of traditional Chinese medicine and the broader health industry.
This also marks the second strategic collaboration with an industry peer that Jointown has undertaken since July, following its partnership with Huahai Pharmaceutical.
Therefore,
Dingdang Kuaiyao and Chunyu Doctor Enter into Strategic Partnership.
Following its strategic partnership with Meituan Waimai, Dingdang Kuaiyao, under the Renhe Group, has recently entered into another strategic alliance with Chunyu Yisheng, a doctor-patient communication platform, to jointly build a closed-loop O2O full industry chain. Notably, Chunyu Yisheng had previously formed a strategic partnership with Haoyaoshi. This collaboration enables resource complementarity across the spectrum, from upstream doctor-patient interactions to downstream pharmaceutical distribution, and from e-commerce to offline physical entities.
Speaking of Chunyu, it is going global.
Recently, Chunyu International Medical was established, focusing on international diagnosis and treatment services. The international business will serve as a supplement to domestic operations, aiming to build a comprehensive, region-wide, full-industry-chain closed loop for internet-based healthcare. According to the business plan, the 75 million existing users of Chunyu’s current product lines will serve as one of the key channels for the initial expansion of its international business. Leveraging its resource and professional advantages in cross-border healthcare, Chunyu International will bridge domestic patients with high-quality medical resources abroad, providing international medical services.
It is understood that the Chunyu International platform primarily offers two major services: online remote consultations and offline cross-border medical treatment. Currently, the platform has contracted with more than 6,000 physicians from over 30 top-tier hospitals worldwide, including the Mayo Clinic, Massachusetts General Hospital (affiliated with Harvard Medical School), MD Anderson Cancer Center, and Chiba University Hospital. These specialists will provide Chinese patients with professional second medical opinions for more than 50 conditions, such as heart disease, cancer, and cardiovascular and cerebrovascular disorders. Additionally, the platform facilitates cross-border medical services—including premium health screenings, cosmetic procedures, and treatment for serious illnesses—in eight countries across the globe, namely the United States, Japan, Germany, South Korea, and Australia.
However, the product is still in the refinement stage and is expected to launch in mid-August. It primarily targets middle-class individuals aged 35 to 50 who possess a certain level of social status and financial stability.
Google Partners with Genealogy Website to Explore the Secrets of Longevity.
Last week, Calico, Google’s anti-aging company, obtained genetic and genealogical data from Ancestry.com, the world’s largest genealogy website, to identify methods for extending lifespan and discover drug targets. Calico will analyze vast amounts of existing genetic data to uncover various factors influencing individual longevity.
At this point, someone must be feeling quite sorrowful.
Health Management Company Vida Launches Cardiac Rehabilitation Campaign, Sponsored by AstraZeneca.
Last week, Vida partnered with AstraZeneca to launch the “Day by Day” campaign, aimed at supporting the health of patients recovering from heart disease. Notably, AstraZeneca covered the costs for patients using healthcare facilities as part of this program.
Vida will assign you a health coach who is well-versed in nutrition, wellness, and psychology. These coaches are available 24/7 via text messaging, with weekly video check-ins. They will ensure that you adhere to medical advice and follow your treatment plan.
Jumei, a cosmetics retailer, invests $300 million in BabyTree.
According to VCBeat, Jumei International (JMEI), an e-commerce company that started with cosmetics, has recently invested in Babytree, a maternal and infant community. The reported investment amount within the industry is $300 million. This marks another O2O-related move by Jumei, following its establishment of physical stores, launch of a breakfast project, and expansion into the beauty industry’s O2O sector. Jumei’s substantial investment in Babytree presents a significant opportunity for the company to expand its product categories and explore the integration of online and offline O2O models.
Yiling Pharmaceutical Partners with Jointown to Establish a National Pharmaceutical Distribution Platform.
Yiling Pharmaceutical and Jointown Pharmaceutical Group have joined forces, aiming to leverage Yiling’s strengths in the research, development, and manufacturing of patented traditional Chinese medicines while integrating Jointown’s channel advantages, thereby achieving synergistic effects across their upstream and downstream industry chains.
Last week, the "Group Strategic Cooperation Agreement" was signed. According to an announcement by Yiling Pharmaceutical, under this cooperation agreement, Yiling Pharmaceutical will be able to leverage the advantages of Jointown Pharmaceutical’s established nationwide pharmaceutical distribution platform to facilitate the sales of its directly manufactured pharmaceutical products, comprehensively enhance its sales capabilities, and intensify market development efforts. Both parties will capitalize on their respective resource advantages, corporate strengths, and market influence to achieve complementary and mutually beneficial collaboration in areas such as e-commerce, procurement, and supply and marketing of Chinese herbal medicines and raw materials.
VCBeat Exclusive
2015 Internet Healthcare Ecosystem Review: Special Report on Medical Imaging
A Traditional Pharmaceutical Company’s Path to Digital Transformation
Cleveland Clinic: The Innovators Alliance for Internet Healthcare
[Overseas Case Study] Inovalon’s Path to IPO: A Medical Big Data Analytics Company
Medical Imaging Series Report 7: Figure.1, Instagram for Doctors Only
Accenture: 5 Medical IT Trends Disrupting the Healthcare Industry
Startup Report |Shanghai Smart Healthcare Cardiology Expert Alliance Established: Core Strategy Combines Equity Incentives and Remote Consultations
Startup Report |Super Vaccine Table: Deepening Grassroots Engagement and Pioneering a New Blue Ocean in Internet Healthcare
The 30 Most Notable Healthcare Startups of 2015: Ginger.io – Your Smartphone as a 360-Degree Health Guardian
Artery Morning Brief |medCPU Raises $8 Million in Funding; NantHealth Acquires Harris Healthcare Solutions
Artery Morning Brief |Two Major Financing Deals Announced in China Yesterday: Gengmei and Maimai Elderly Care Secure Tens of Millions in Funding
Artery Morning Brief |According to statistics, are robotic surgeons killing people?
VCBeat Morning Brief |Jiyun Huikang Uses Alibaba Cloud Batch Computing for Whole-Genome Sequencing
Artery Morning Brief |YaoPin ZhongDuan Wang Completes Tens of Millions in Series A+ Funding
Interpretation of Trending English Terms in Internet Healthcare:ATA/AMR
Healthcare Reform
The State Council Determines the Full Implementation of Critical Illness Insurance for Urban and Rural Residents:Recently, the State Council’s executive meeting decided to allocate a certain proportion or amount from the basic medical insurance funds for urban residents and the New Rural Cooperative Medical Scheme (NRCMS) as funding for critical illness insurance. By the end of 2015, critical illness insurance will cover all participants in the basic medical insurance programs for both urban and rural residents, providing coverage for the out-of-pocket medical expenses incurred by insured patients with critical illnesses. The reimbursement rate will reach over 50% this year and will be gradually increased in the future, effectively alleviating the financial burden of medical treatment for patients with critical illnesses. By 2017, a relatively comprehensive critical illness insurance system will be established.
OTC Drugs to Be Removed from the National Reimbursement Drug List in Phases:According to a report by Yicai Daily, 556 over-the-counter (OTC) drugs currently included in the National Reimbursement Drug List (NRDL)—comprising 200 chemical drugs and 356 proprietary Chinese medicines—will be phased out in batches. Although relevant authorities have not yet reached a final consensus on the specific timeline and methodology for this removal, it has been confirmed that no new OTC varieties will be added to the upcoming NRDL.
Because the medical insurance fund can no longer sustain the pressure. In pooled regions, expenditures exceed revenues, placing an unbearable burden on medical insurance funds; moreover, the growth rates of expenditures for various medical insurance funds now all surpass their revenue growth rates.
Data
2015–2016 U.S. News Best Hospitals Rankings: Massachusetts General Hospital Tops the List Again:Massachusetts General Hospital in Boston has once again been ranked No. 1 among America’s Best Hospitals. Massachusetts General Hospital topped the list in 2012 and ranked second in 2013 and 2014. The Mayo Clinic, which held the top spot last year, ranks second this year. Johns Hopkins Hospital and UCLA Medical Center are tied for third place.
China's Annual Antibiotic Consumption Reaches 160,000 Tonnes, Accounting for Half of the Global Total:Recent findings released by the Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, reveal that antibiotic consumption in mainland China reached an astonishing 162,000 metric tons in 2013, accounting for approximately half of the global total. Of this amount, 52% was used for veterinary purposes and 48% for human medical use, resulting in per capita antibiotic consumption five to eight times higher than that in Western countries. More than 50,000 metric tons of antibiotics were discharged into soil and water environments.
The Asia-Pacific Hypertension Treatment Market Will Reach $20 Billion in 2021:Global market research firm GBI Research released a report stating that the hypertension treatment market in four Asia-Pacific (APAC) countries—China, India, Australia, and Japan—will grow steadily at a compound annual growth rate (CAGR) of 3.4% over the next six years (2015–2021), reaching $19.9 billion by 2021, up from $15.7 billion in 2014. The report attributes this modest growth primarily to low awareness of hypertension, which has resulted in suboptimal diagnosis and treatment rates.
It was also pointed out that over the next six years, India’s hypertension treatment market will experience the fastest growth, with a CAGR of 12.6%, rising from a market value of only $800 million in 2014 to $1.9 billion by 2021. Additionally, among the four Asia-Pacific countries, India’s annual cost of treatment (ACoT) for hypertension is very low, amounting to less than one-tenth of that in Japan.
Precision Manufacturing Outsourcing Becomes Mainstream in the Orthopedics Market:According to the Orthopedic Trends Watch report released by Ortho Streams, the global orthopedic products market, valued at $3.55 billion, is growing at an annual rate of 3.5% and is projected to reach $3.8 billion in 2015. This growth is primarily driven by factors such as population aging, individuals’ expectations to remain active throughout their lifespan, the continuing rise in obesity, and expanded health insurance coverage. Spinal, knee, hip, and trauma products account for more than 65% of the total orthopedic products market. The increasing trend of outsourcing and supplier restructuring will further propel the expansion of the precision manufacturing outsourcing market.
Personal Health Data Spurs New Forms of Collaboration in the Pharmaceutical Industry:In a newly released report, PwC pointed out that novel personal wearable devices can collect patient health data. Payers and providers seeking to compress pharmaceutical costs are integrating patient personal information with data on patient responses to medications. In some cases, pharmaceutical companies concerned about falling behind are also striving to consolidate all such data, leveraging the power of big data to conduct comprehensive industry analyses in an effort to lower drug prices and drive the development of the pharmaceutical industry.
The report recommends that companies not yet engaged in novel collaborative models should consider partnerships not only with payers and suppliers but also with technology firms and patient advocacy groups, to better understand how their medications perform in real-world settings. The next step is to increase the utilization of data provided by patients through personal health devices.
New Technologies
Osaka University in Japan Claims Dissolvable Microneedle Patches Could Replace Vaccine Injections
Researchers at Osaka University in Japan reported in the journal Biomaterials that they have developed a new microneedle patch that dissolves in the skin. Compared with standard vaccine injection methods, this new approach makes vaccination simpler, safer, and less painful.
No More Finger Pricks for Blood Glucose Testing!
Professor Gin Jose and his team at the University of Leeds in the United Kingdom have developed a new technology that uses a small device equipped with a low-energy laser to measure blood glucose levels without pricking the finger, offering a simple and painless experience. Even more impressively, this technology enables continuous monitoring of blood glucose levels. If developed into a wearable device, it would allow patients with diabetes to monitor their blood glucose levels at any time. The device can also automatically issue alerts when treatment is required. The team hopes to transmit data directly to physicians, enabling them to create patient profiles and record disease progression.
"Magical Sensor Turns Brushing into a 'Game'"
At the Second Chuangzhi Conference, participating middle school students showcased their creativity by transforming toothbrushing into an enjoyable game. The secret behind this transformation lies in two innovative sensors: a paper-thin sensor (based on the latest research from Princeton University) that can be placed between teeth to capture information about dental plaque colonies. This data is then processed and projected onto a “mirror” screen, where it appears as “monsters” waiting to be defeated. A second sensor, embedded in the toothbrush, captures brushing motions; as users perform correct brushing techniques, the “monsters” are eliminated one by one. Of course, this “mirror” is actually a specialized gaming display device, which still serves its conventional purpose of allowing users to check their appearance when not in use.
Purdue University Develops "Smart Capsule" to Deliver Drugs Directly to the Large Intestine
Barbabak Ziaie, a Professor of Electrical and Computer Engineering at Purdue University in the United States, along with Rudolf Pinal, an Associate Professor of Industrial and Physical Pharmacy, and their colleagues, have developed a new “smart capsule” capable of delivering drugs directly to the large intestine for targeted therapy. This innovation holds promise for treating irritable bowel syndrome (IBS) and Crohn’s disease, as well as combating infections caused by Clostridioides difficile, a potentially life-threatening bacterium. In clinical practice, fecal microbiota transplantation from a healthy donor into the patient’s colon is sometimes required to treat C. difficile infection, as it provides essential microbes. According to Ziaie, their approach can also convert these microbes into a powder via freeze-drying technology and deliver them using the smart capsule.
Capital
